Table of Content

1. Table of Contents
1.1 List of Tables
1.2 List of Figures


2. Executive Summary
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Cancer Diagnostics Market- Key Findings, 2020


3. Strategic Imperatives on Global Cancer Diagnostics Market
3.1 COVID-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End User Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Cancer Diagnostics Companies


4. Cancer Diagnostics Market Value Outlook to 2026, by Type
4.1 Diagnostic Imaging Tests
4.2 Biopsy and Cytology Tests
4.3 Tumor Biomarkers
4.4 Other Diagnostic Types


5. Cancer Diagnostics Market Value Outlook to 2026, by Applictaion
5.1 Breast Cancer
5.2 Lung Cancer
5.3 Cervical Cancer
5.4 Kidney Cancer
5.5 Liver Cancer
5.6 Pancreatic Cancer
5.7 Ovarian Cancer
5.8 Other Applications


6 Asia Pacific Cancer Diagnostics Market Value Outlook to 2026
6.1 Leading Cancer Diagnostics Types contributing to Asia Pacific market
6.2 Top Applications contributing to Asia Pacific Cancer Diagnostics
6.3 Top countries contributing to Asia Pacific Cancer Diagnostics


7 Europe Cancer Diagnostics Market Value Outlook to 2026
7.1 Leading Cancer Diagnostics Types contributing to Europe market
7.2 Top Applications contributing to Europe Cancer Diagnostics
7.3 Top countries contributing to Europe Cancer Diagnostics


8 North America Cancer Diagnostics Market Value Outlook to 2026
8.1 Leading Cancer Diagnostics Types contributing to North America market
8.2 Top Applications contributing to North America Cancer Diagnostics
8.3 Top countries contributing to North America Cancer Diagnostics


9 South and Central America Cancer Diagnostics Market Value Outlook to 2026
9.1 Leading Cancer Diagnostics Types contributing to South and Central America market
9.2 Top Applications contributing to South and Central America Cancer Diagnostics
9.3 Top countries contributing to South and Central America Cancer Diagnostics


10 Middle East Africa Cancer Diagnostics Market Value Outlook to 2026
10.1 Leading Cancer Diagnostics Types contributing to Middle East Africa market
10.2 Top Applications contributing to Middle East Africa Cancer Diagnostics
10.3 Top countries contributing to Middle East Africa Cancer Diagnostics


11 Business Profiles of Leading Companies
11.1 Business Description, SWOT and Financial Analysis of Companies in Cancer Diagnostics market
11.2 Abbott
11.3 Agilent Technologies Inc.
11.4 F. Hoffmann-La Roche Ltd
11.5 GE Healthcare
11.6 Hologic Inc.
11.7 Illumina Inc.
11.8 Philips Healthcare
11.9 Qiagen
11.10 Siemens Healthcare GmbH
11.11 Thermo Fisher Scientific Inc.


12 Recent Industry Developments


13 Appendix
13.1 OGAnalysis Expertise
13.2 Sources and Methodology
13.3 Contacts